"After another four months or so on antidepressants, bringing me to a total of 10 months between the steroids and antidepressants, I was suddenly flipped into this hypomania."
"32% of the advertisements [in peer reviewed journals] misled readers regarding efficacy, 40% did not provide balanced descriptions of the side effects, and 44% could lead to improper prescribing if the physician did not use other sources of information regarding the drug."
Correction! A panel calling itself the Institute of Medicine as a Profession (IMP) is calling for a ban on the intermingling of industry and academic scholars and physicians. This is NOT affiliated with the Institute of Medicine (IOM)
This issue is NOT about trial lawyers, this issue is about the rights and health, and safety of ordinary citizens.
Fortune Magazine confirms our report (October) that "The prospect of a bird flu outbreak may be panicking people around the globe, but it’s proving to be very good news for Defense Secretary."
Two items in today’s New York Times illustrate the contrast between what the Administration claims it’s legislative / regulatory proposals will do for health care, and what they actually do after they’ve taken effect.
On Tuesday evening, 38 U.S. Senators with about $13.4 million in pharmaceuticaql stock holdings approved a sweetheart deal absolving the drug / vaccine industry from liability .
Dr. Scott Gottlieb’s ties to drug firms spark questions over agency hiring policies
Dr. Carl Elliott's insightful essay in SLATE:: Why do drug companies want to give money to bioethicists in the first place? In the public relations business, this approach is called "third-party strategy."
Dr. Jeffrey Levine, a psychiatrist from Albert Einstein dubbed this year's annual meeting in Philadelphia, "the American Psychiatric Association GlaxoSmithKline Convention."
